Home Micell Technologies

Micell Technologies

In operation
Series A
Cardiovascular Disease Treatment Device Research Company

Basic Information

Micell Technologies is an innovative technology company dedicated to transforming medical devices and improving patient outcomes. The company's supercritical fluid technology is a key component of an enhanced drug delivery system, which is currently used in the interventional cardiology market but has potential far-reaching applications in the treatment of cardiovascular diseases. Micell is committed to eliminating the typical limitations of existing technologies used for manufacturing drug-eluting medical devices and is focused on bringing this unique approach to market. The company’s flagship product, MiStent®, is a CE-marked drug-eluting stent that allows for controlled drug release and pharmacokinetics.
Micell Technologies,Inc
Raleigh,NorthCarolina,United States of America
15~50 people
January 01, 1995
info@micell.com